Search Results 1691-1700 of 16035 for ozempic

  1. Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies - Mayo Clinic

    This is a phase 1, open-label, multicenter, ascending-dose escalation study of REGN2810, alone and in combination with other anti-cancer therapies in patients ...

  2. Muscle Protein Metabolism in Obesity - Mayo Clinic

    About this study. Obesity is associated with reduced adenosine triphosphate (ATP) turnover in skeletal muscle, a condition that can impair muscle metabolism ...

  3. A Study to Evaluate the Safety, Tolerability, Drug/Body Interactions, and Activity of Oradoxel for Patients with Advanced Malignancies - Mayo Clinic

    The purpose of this study is to determine the safety, tolerability, activity, and drug/body interactions of Oradoxel for the treatment of patients who have ...

  4. Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52- ...

  5. News - John J. Weroha, M.D., Ph.D. - Mayo Clinic

    Search for a doctor. John J. Weroha, M.D., Ph.D. Internist; Oncologist. Request an Appointment · Overview · News. News.

  6. Publications - Ala S. Dababneh, M.D. - Mayo Clinic

    Lessard S, Huiras C, Dababneh A, Palraj R, Thies R, Woolever N, Holt K, Schwan B, Poelma J, Tempelis J, Sawyer M. Pharmacist adjustment of preoperative ...

  7. ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE) - Mayo Clinic

    About this study. The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in ...

  8. A Phase 2/3 Study of Indoximod or Placebo Plus Pembrolizumab or Nivolumab in Subjects With Unresectable or Metastatic Melanoma - Mayo Clinic

    About this study. This is an adaptive clinical trial that includes a dose escalation phase followed by a randomized controlled Phase 3 trial.

  9. Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-52) - Mayo Clinic

    This is a study using pembrolizumab (MK-3475, KEYTRUDA®) for first-line treatment of participants with advanced/unresectable (inoperable) or metastatic ...

  10. Changes in Gut Microbiota after Endoscopic Procedures for the Treatment of Obesity - Mayo Clinic

    About this study. The purpose of this study is to learn more about the effects of similar weight loss through caloric restriction, gastric reduction, ...